Are you Dr. Nelson?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 41 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1959 Ne Pacific St
Seattle, WA 98195Phone+1 206-520-5307Fax+1 206-520-5620- Is this information wrong?
Summary
- Dr. Peter Nelson, MD is a nephrologist in Seattle, Washington. He is currently licensed to practice medicine in Washington. He is affiliated with UW Medicine/University of Washington Medical Center.
Education & Training
Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalFellowship, Nephrology, 1999 - 2003- Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Internal Medicine, 1997 - 1999
- Icahn School of Medicine at Mount SinaiClass of 1997
Certifications & Licensure
WA State Medical License 2009 - 2026
Awards, Honors, & Recognition
- Fellow (ASNF) American Society of Nephrology
Clinical Trials
- MEmbranous Nephropathy Trial Of Rituximab Start of enrollment: 2011 Nov 01
- Nephrotic Syndrome Study Network Start of enrollment: 2010 Apr 01
- Phenelzine Sulfate and Docetaxel in Treating Patients With Prostate Cancer With Progressive Disease After First-Line Therapy With Docetaxel Start of enrollment: 2010 Jul 12
Publications & Presentations
PubMed
- 44 citationsThe relatively poor correlation between random and 24-hour urine protein excretion in patients with biopsy-proven glomerular diseasesMarie C. Hogan, Heather N. Reich, Peter J. Nelson, Sharon G. Adler, Daniel C. Cattran, Gerald B. Appel, Debbie S. Gipson, Matthias Kretzler, Jonathan P. Troost, John C...> ;Kidney International. 2016 Nov 1
- A Phase 2, Double-Blind, Placebo-Controlled, Randomized Study of Fresolimumab in Patients With Steroid-Resistant Primary Focal Segmental Glomerulosclerosis.Vincenti, F.,Fervenza, F. C.,Campbell, K. N.,Diaz, M.,Gesualdo, L.,Nelson, P.,Praga, M.,Radhakrishnan, J.,Sellin, L.,Singh, A.,Thornley-Brown, D.,Veronese, F. V.,Accom...> ;Kidney Int Rep. 2017 Dec 23
- 35 citationsEfficacy and Safety of Sparsentan Compared With Irbesartan in Patients With Primary Focal Segmental Glomerulosclerosis: Randomized, Controlled Trial Design (DUET).Radko Komers, Debbie S. Gipson, Peter T. Nelson, Sharon G. Adler, Tarak Srivastava, Vimal K. Derebail, Kevin E.C. Meyers, Pablo E. Pergola, Meghan E. MacNally, Jennife...> ;Kidney International Reports. 2017 Jul 1
- Join now to see all
Professional Memberships
- Fellow
Hospital Affiliations
UW Medicine/University of Washington Medical CenterSeattle, Washington
